Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Spero Therapeutics, Inc. (SPRO)

1.0600 -0.0500 (-4.50%)
At close: October 30 at 4:00:01 PM EDT
1.0795 +0.0195 (+1.84%)
After hours: October 30 at 5:47:23 PM EDT
Trade SPRO on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
42,964
59,619
27,396
96,735
48,579
Operating Expense
36,352
52,460
99,880
69,948
79,146
Operating Income
6,612
7,159
-72,484
26,787
-30,567
Net Non Operating Interest Income Expense
1,621
2,512
4,735
3,937
-1,499
Other Income Expense
-589
-838
-817
-5,320
-14,349
Pretax Income
7,644
8,833
-68,566
25,404
-46,415
Tax Provision
--
261
0
2,598
0
Net Income Common Stockholders
7,383
8,572
-68,566
22,806
-46,415
Diluted NI Available to Com Stockholders
7,383
8,572
-68,566
22,806
-46,415
Basic EPS
0.14
0.15
-1.27
0.43
-1.23
Diluted EPS
0.14
0.15
-1.27
0.43
-1.23
Basic Average Shares
56,982.2180
56,020.3630
54,037.9170
52,703.4670
37,585.0750
Diluted Average Shares
60,001.0800
59,039.2250
54,037.9170
52,989.0300
37,585.0750
Total Operating Income as Reported
6,025
6,314
-73,361
21,481
-42,197
Total Expenses
36,352
52,460
99,880
69,948
79,146
Net Income from Continuing & Discontinued Operation
7,383
8,572
-68,566
22,806
-46,415
Normalized Income
7,735.2000
9,391.6500
-67,689
27,570.7880
-35,702
Interest Income
1,621
2,512
4,735
3,937
1,106
Interest Expense
--
--
--
0
2,605
Net Interest Income
1,621
2,512
4,735
3,937
-1,499
EBIT
6,612
7,159
-72,484
26,787
-43,810
EBITDA
6,612
7,159
-72,482
27,154
-42,941
Reconciled Depreciation
--
0
2
367
869
Net Income from Continuing Operation Net Minority Interest
7,383
8,572
-68,566
22,806
-46,415
Total Unusual Items Excluding Goodwill
-587
-845
-877
-5,306
-10,713
Total Unusual Items
-587
-845
-877
-5,306
-10,713
Normalized EBITDA
7,199
8,004
-71,605
32,460
-32,228
Tax Rate for Calcs
0.0004
0
0
0.0001
0
Tax Effect of Unusual Items
-234.8000
-25.3500
0
-541.2120
0
12/31/2022 - 11/2/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: